The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation ...
The Conejo Valley’s life science moment is here — driven by global leaders, emerging innovators, modern infrastructure, and a skilled workforce.
CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing ...
Setting a new milestone, the Indian government on November 20 launched an indigenous CRISPR-based gene therapy for Sickle Cell Disease, which particularly affects India's tribal population. The ...
If the gene therapy treatment is proven to be effective in curing the sickle cell disease, it will initially be made available to people with severe sickle cell disease, maybe with organ damage.
In conjunction with Tract’s move to Connect Labs Charlotte, the company’s scientific co-founders, Frank McKeon, Ph.D., and Wa ...
Lyric Bio, Inc., (Lyric) a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics, has closed an oversubscribed $6.6 million seed ...
当代职场人“熬夜+酒局+高压”三件套已成常态,肝脏被迫“007”加班,脸色暗沉、代谢变慢、脂肪肝年轻化成为普遍痛点。市场上护肝产品从传统的“水飞蓟单方”到如今的“复合修护”层出不穷,消费者该如何选择?
STK-012 is an α/β biased IL-2 partial agonist designed to stimulate antigen-activated T cells while avoiding IL-2 associated toxicities Positive Phase 1b data recently presented at SITC 2025, with a ...
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the ...
Menstrual blood is emerging as a powerful tool in women’s health, offering promising diagnostic accuracy and regenerative ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈